India, Sept. 22 -- Dr Dangs Lab in Delhi has launched a non-invasive early detection test - Dendrite Dx - for Alzheimer's disease on the occasion of World Alzheimer's Day on Sunday, the company informed.

"Dr Dangs Lab unveils an integrated diagnostics pathway for precision brain health - that begins with digital cognitive assessments and blood-based biomarkers to screen mild cognitive decline, then progresses to stepwise reflex testing for Alzheimer's, including FDA-approved biomarkers, targeted genotyping, and an exclusive proprietary confirmatory test in collaboration with C2N Diagnostics (USA)," read the statement by Dr Dangs Lab.

According to government estimates, Alzheimer's affects at least 55 million people worldwide and is likel...